HGF and RhoGTPases in Cancer Cell Motility

E-ISSN： 2212-389x|6|2|173-179

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.6, Iss.2, 2011-05, pp. : 173-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor Cell Motility as a Novel Target in Cancer – Experimental and Clinical Results

Oncology Research and Treatment, Vol. 25, Iss. 2, 2002-05 ,pp. : 172-177

Karger

Access to resources Recommend Favorite

Implication of small GTPases Rho in endothelial response to high dose of ionizing radiation.

By Rousseau M. Rodallec A. Bonnaud S. Paris F. Corre I.

Radioprotection, Vol. 43, Iss. 5, 2008-09 ,pp. : 111-111

Edp Sciences

Access to resources Recommend Favorite

Coup d’œil sur les petites GTPases Rho

By Primeau Martin Lamarche-Vane Nathalie

Médecine/sciences, Vol. 24, Iss. 2, 2010-12 ,pp. : 157-162

Edp Sciences

Access to resources Recommend Favorite

Androgen receptor enhances entosis, a non‐apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells

THE PROSTATE, Vol. 73, Iss. 12, 2013-09 ,pp. : 1306-1315

John Wiley & Sons Inc

Access to resources Recommend Favorite

HGF-Antagonists: Structure, Activities, and Anti-cancer Approach

Current Signal Transduction Therapy, Vol. 6, Iss. 2, 2011-05 ,pp. : 191-199

Bentham Science Publishers

Access to resources Recommend Favorite